Viking Therapeutics' VK0214 Receives FDA Orphan... - AMN EASIER

AMN EASIER

1,312 members1,164 posts

Viking Therapeutics' VK0214 Receives FDA Orphan Drug Designation for the Treatment of X-Linked Adrenoleukodystrophy

wilburlois15 profile image
2 Replies

This is important, and also current! Not holding my breath but it's a step forward

checkorphan.org/news/viking...

Written by
wilburlois15 profile image
wilburlois15
To view profiles and participate in discussions please or .
2 Replies
KeithS profile image
KeithS

Sounds like a good start. A long time since there's been anything offering some hope of a reduction of our symptoms.

deengo profile image
deengo

I contacted Viking and gave the number to my neurologist who I found out also called them. The big surprise was they actually called me back to confirm she was my neurologist. That's something. Hopefully this goes somewhere.

You may also like...

Viking Therapeutics drug VK0214-102

a trial for the Viking Therapeutics drug VK0214-102, which is a potential treatment for AMN....